Panagora Asset Management Inc Idera Pharmaceuticals, Inc. Transaction History

Panagora Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$1.0 - $1.18 $653 - $770	-653 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$1.01 - $1.58 $33 - $52	-33 Reduced 4.81%	653 $1,000
Q4 2020 Feb 10, 2021	BUY	$2.09 - $5.18 $1,433 - $3,553	686 New	686 $3,000
Q1 2020 May 14, 2020	SELL	$1.06 - $2.15 $267 - $541	-252 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$2.33 - $3.79 $4,867 - $7,917	-2,089 Reduced 89.24%	252 $1,000

Q3 2018 Nov 13, 2018	SELL	$5.53 - $11.36 $90,664 - $186,247	-16,395 Reduced 87.51%	2,341 $21,000
Q2 2018 Aug 14, 2018	BUY	$9.92 - $16.96 $185,861 - $317,762	18,736 New	18,736 $25,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.